Tunable and reversible drug control of protein production via a self-excising degron

SMASh is a strategy for regulating protein stability, in which treatment with a small molecule targets a protein tagged with a self-removing degron that includes an HCV protease sequence. SMASh was used to target measles virus phosphoprotein P, for which no inhibitors exist.